跳至主要内容
临床试验/CTRI/2016/11/007435
CTRI/2016/11/007435已完成未知

A Poly herbal for Control of Blood Sugar in Subjects With Impaired Glucose Toleranceand/or Early Type 2 Diabetes. A Randomized Placebo Controlled Study of a Poly herbal(Whole Herb Formulation)

Organic India0 个研究点目标入组 122 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
Organic India
入组人数
122

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adult males and non-pregnant females aged >=30 years having a diagnosis of pre-diabetes (impaired fasting glucose or impaired glucose tolerance) or diabetes and meeting one of the following criteria
  • 1.Fasting Plasma Glucose >=100 mg/dL, fasting is defined as no caloric intake for at least 8 h, OR
  • 2.2-h Post load Glucose >=140 mg/dL during an OGTT. The test should be performed as described by the WHO, using a glucose load containing the equivalent of 75 g anhydrous glucose dissolved in water. OR
  • 3.Glycosylated haemoglobin (A1C) >=5.7%. The test should be performed in a laboratory using a method that is NABL certified and standardized. OR
  • 4.In a patient with classic symptoms of hyperglycaemia or hyperglycaemic crisis, a random plasma glucose >=200 mg/dL in the last 12 months.

排除标准

  • Any one of the following
  • 1.History of diabetes onset >12 months from date of randomization and/or on any oral hypoglycemic agents (other than metformin) or Insulin.
  • 2.Any history suggestive of micro vascular or macro vascular disease
  • 3.Women in child bearing age unable to practice any form of contraception
  • 4.Impaired renal function; eGFR <60mls/min/1.73m2.
  • 5.Known history of any chronic illness taking regular pharmacological agents.
  • 6.Blood pressure fluctuations exceeding 10mmHg on 2 subsequent clinic visits or known history of hypotension or bradycardia in last 6 months or taking 2 or more antihypertensive medications regularly in the last 6 weeks
  • 7.Current or former employees of organic India
  • 8.Participating in another clinical trial with an active intervention or drug or device with last dose taken within 60 days.
  • 9.Refusing consent or physician uncomfortable with patient compliance to treatments or follow up.

研究者

发起方
Organic India

相似试验